The utility of claudin‐4 versus MOC‐31 and Ber‐EP4 in the diagnosis of metastatic carcinoma in cytology specimens

Claudin-4 shows superior specificity for mesothelioma vs non–small-cell lung carcinoma compared with MOC-31 and Ber-EP4

(2020) Julia R. Naso et al.   HUMAN PATHOLOGY

The “Brescia panel” (Claudin‐4 and BRCA‐associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas

(2020) Livia Bernardi et al.   CANCER CYTOPATHOLOGY

Claudin‐4 immunohistochemistry is a useful pan‐carcinoma marker for serous effusion specimens

(2019) Melissa Vojtek et al.   CYTOPATHOLOGY

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

(2018) Aliya Noor Husain et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Diagnostic Usefulness of Claudin-3 and Claudin-4 for Immunocytochemical Differentiation between Metastatic Adenocarcinoma Cells and Reactive Mesothelial Cells in Effusion Cell Blocks

(2016) Nah Ihm Kim et al.   ACTA CYTOLOGICA

Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology

(2016) Tomohiro Oda et al.   DIAGNOSTIC CYTOPATHOLOGY

Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology

(2014) Vickie Y. Jo et al.   CANCER CYTOPATHOLOGY

Value of Claudin-4 Immunostaining in the Diagnosis of Mesothelioma

(2013) Nelson G. Ordóñez   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions

(2010) Silvia Lonardi et al.   DIAGNOSTIC CYTOPATHOLOGY